feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Dual Cancer Fight: Lung Tumor Found Alongside Breast Cancer

Dual Cancer Fight: Lung Tumor Found Alongside Breast Cancer

28 Nov, 2025

•

Summary

  • Lung tumor identified as a separate neuroendocrine malignancy, not breast cancer spread.
  • Patient received neoadjuvant hormone and targeted therapies for both cancers.
  • Complete regression of breast cancer and bone metastasis observed post-treatment.
Dual Cancer Fight: Lung Tumor Found Alongside Breast Cancer

A remarkable case has highlighted the importance of thorough diagnostics, where a patient initially diagnosed with advanced breast cancer was found to harbor a second, independent malignancy. Experts identified the lung tumor as a neuroendocrine tumor, a distinct cancer not originating from the breast disease, necessitating a unique therapeutic strategy.

This crucial distinction enabled doctors to pursue curative intent for both conditions. The patient underwent neoadjuvant hormone therapy, targeted treatments, and bone-protective agents. Within three months, scans revealed a complete regression of the breast tumor and bone metastases, alongside a significant reduction in other breast tumors.

trending

Unemployment rate dipped to 4.4%

trending

BCA withdraws ICE shooting investigation

trending

US jobs data Friday

trending

McIntyre wins WWE Championship

trending

Morocco beats Cameroon in AFCON

trending

Max Kepler suspended 80 games

trending

Wrexham beats Nottingham Forest

trending

Bissouma, Sarr face off

trending

Anthony Davis hand injury update

The lung tumor remained stable, paving the way for sequential surgeries to address both cancers. This patient's journey offers a powerful testament to overcoming advanced-stage illness, inspiring hope for others facing similar challenges.

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Yes, a lung tumor can be an independent malignancy, like a neuroendocrine tumor, distinct from breast cancer metastasis.
The patient received neoadjuvant hormone therapy, targeted therapies, and bone-protective agents for both breast and lung tumors.
Studies show the 5-year survival rate for Stage IV breast cancer in India is approximately 24.5%.

Read more news on

Healthside-arrow

You may also like

Beyond Lifestyle: Unveiling Genetic Cancer

17 hours ago • 2 reads

article image

Itchy Skin? Could It Be Cancer?

1 day ago • 8 reads

article image

Cancer Treatment Timing Matters: Early Doses Boost Survival

23 Dec, 2025 • 80 reads

article image

King Shares Health Milestone: Cancer Treatment Reduced

13 Dec, 2025 • 131 reads

article image

Tumor vs. Cancer: Clearing the Medical Confusion

8 Dec, 2025 • 148 reads

article image